Unknown

Dataset Information

0

Towards precision medicine in Alzheimer's disease: deciphering genetic data to establish informative biomarkers.


ABSTRACT: INTRODUCTION:Developing biomarker tools for identification of individuals at high-risk for late-onset Alzheimer's disease (LOAD) is important for prognosis and early treatment. This review focuses on genetic factors and their potential role for precision medicine in LOAD. AREAS COVERED:APOEe4 is the strongest genetic risk factor for non-Mendelian LOAD, and the APOE-linkage disequilibrium (LD) region has produced the most significant association signal in multi-center genome-wide-association-studies (GWAS). Consideration of extended haplotypes in the APOE-LD region and specifically, non-coding variants in putative enhancer elements, such as the TOMM40-polyT, in-addition to the coding variants that comprise the APOE-genotypes, may be useful for predicting subjects at high-risk of developing LOAD and estimating age-of-onset of early disease-stage symptoms. A genetic-biomarker based on APOE-TOMM40-polyT haplotypes, and age is currently applied in a clinical trial for prevention/delay of LOAD onset. Additionally, we discuss LOAD-GWAS discoveries and the development of new genetic risk scores based on LOAD-GWAS findings other than the APOE-LD region. EXPERT COMMENTARY:Deciphering the precise causal genetic-variants within LOAD-GWAS regions will advance the development of genetic-biomarkers to complement and refine the APOE-LD region based prediction model. Collectively, the genetic-biomarkers will be translational for early diagnosis and enrichment of clinical trials with subjects at high-risk.

SUBMITTER: Chiba-Falek O 

PROVIDER: S-EPMC5605187 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature

altmetric image

Publications

Towards precision medicine in Alzheimer's disease: deciphering genetic data to establish informative biomarkers.

Chiba-Falek Ornit O   Lutz Michael W MW  

Expert review of precision medicine and drug development 20170201 1


<h4>Introduction</h4>Developing biomarker tools for identification of individuals at high-risk for late-onset Alzheimer's disease (LOAD) is important for prognosis and early treatment. This review focuses on genetic factors and their potential role for precision medicine in LOAD.<h4>Areas covered</h4><i>APOE</i>e4 is the strongest genetic risk factor for non-Mendelian LOAD, and the <i>APOE</i>-linkage disequilibrium (LD) region has produced the most significant association signal in multi-center  ...[more]

Similar Datasets

2019-02-27 | GSE127208 | GEO
| S-EPMC5606033 | biostudies-literature
| S-EPMC6477790 | biostudies-literature
| S-EPMC7192849 | biostudies-literature
| S-EPMC7809753 | biostudies-literature
| S-EPMC4456621 | biostudies-other
2019-03-15 | GSE125216 | GEO
| S-EPMC6116075 | biostudies-literature
| S-EPMC6805787 | biostudies-literature
| PRJNA524343 | ENA